scispace - formally typeset
Journal ArticleDOI

Treatment of Advanced Melanoma in 2020 and Beyond.

Russell W. Jenkins, +1 more
- 01 Jan 2021 - 
- Vol. 141, Iss: 1, pp 23-31
TLDR
The clinical progress in management of advanced melanoma is reviewed and the impact of the same therapies on earlier stage disease is discussed, where the agents have shown significant promise in treating resectable but high-risk clinical scenarios.
About
This article is published in Journal of Investigative Dermatology.The article was published on 2021-01-01. It has received 170 citations till now. The article focuses on the topics: Vemurafenib & Talimogene laherparepvec.

read more

Citations
More filters
Journal ArticleDOI

Fabricated Metal-Organic Frameworks (MOFs) as luminescent and electrochemical biosensors for cancer biomarkers detection

TL;DR: In this paper, the authors analyzed porous fabricated metal-organic frameworks (MOFs) that have better structures and porosities for enhanced biomarker sensing and presented an innovative technique to detect the cancer biomarkers by the use of luminescence and electrochemical MOF sensors.
Journal ArticleDOI

Systemic Therapy of Metastatic Melanoma: On the Road to Cure.

TL;DR: A recent review as mentioned in this paper summarizes prospectively and retrospectively generated clinical evidence on modern melanoma therapy, focusing on immunotherapy and targeted therapy with BRAF and MEK kinase inhibitors (BRAF/MEK inhibitors), including recent data presented at major conference meetings.
Journal ArticleDOI

Hypoxia-dependent drivers of melanoma progression

TL;DR: In this article, the latest progress in hypoxia-regulated pathways involved in the development and progression of all melanoma subtypes were discussed, and the authors summarized current knowledge on preclinical studies with drugs targeting HypoxiaInducible Factor-1, angiogenesis or vasculogenic mimicry.
Journal ArticleDOI

The Treatment of Advanced Melanoma: Therapeutic Update

TL;DR: The aim of this review is to assess and to discuss the role of emerging therapies for AM management in order to obtain a complete overview of the currently available treatment options and future perspectives.
Journal ArticleDOI

Tumor microenvironment-responsive Ag2S-PAsp(DOX)-cRGD nanoparticles-mediated photochemotherapy enhances the immune response to tumor therapy

TL;DR: Wang et al. as mentioned in this paper constructed a tumor microenvironment-responsive drug delivery system (Ag2S-PAsp-cRGD) combined with doxorubicin (DOX) for tumor therapy.
References
More filters
Journal ArticleDOI

The blockade of immune checkpoints in cancer immunotherapy

TL;DR: Preliminary clinical findings with blockers of additional immune-checkpoint proteins, such as programmed cell death protein 1 (PD1), indicate broad and diverse opportunities to enhance antitumour immunity with the potential to produce durable clinical responses.
Related Papers (5)

Genomic Classification of Cutaneous Melanoma

Rehan Akbani, +351 more
- 18 Jun 2015 -